Fereshteh Baygi1, Olaf C Jensen2, Mostafa Qorbani3, Aliasghar Farshad1, Seyed Ali Salehi4, Fatemeh Mohammadi5, Hamid Asayesh6, Farzad Shidfar7. 1. Occupational Health Research Center, Iran University of Medical Sciences, Tehran, Iran. 2. Centre of Maritime Health and Society, Institute of Public Health, University of Southern Denmark, Esbjerg, Denmark. 3. Department of Public Health, Alborz University of Medical Sciences, Karaj, Iran. 4. National Iranian Tanker Company, Tehran, Iran. 5. Department of Food and Nutrition Policy and Planning Research, National Nutrition and Food Technology Research Institute, Faculty of Nutrition Sciences and Food Technology, Shahid Beheshti University of Medical Sciences, Tehran, Iran. 6. Department of Medical Emergencies, Qom University of Medical Sciences, Qom, Iran. 7. Department of Nutrition, School of public Health, Iran University of Medical Sciences, Tehran, Iran.
Abstract
Background: Little information is available on the trend in cardiovascular risk factors and hepatic enzymes in Iranian seafarers. The present study aimed at assessing the pattern of obesity, hypertension, diabetes, elevated serum glutamic oxaloacetate transaminase (SGOT), and serum glutamate pyruvate transaminase (SGPT) in Iranian seafarers during 2010 to 2014. Methods: Data on cardiovascular risk factors and hepatic enzymes were extracted from seafarers' annual health examination of National Iranian Tanker Company (NITC) of 2010, 2012, and 2014. The repeated measure ANOVA was used to compare continuous variables across 3 years. Categorical data were analyzed using Chi-square test. Over weight was defined as BMI (Body Mass Index) >25 kg/m2; obesity was defined as BMI>=30 kg/m2; hypertension was defined as systolic blood pressure (SBP)> 140 mmHg, and diastolic blood pressure (DBP)> 90 mmHg, or a history of antihypertensive drug use. Diabetes (DM) was defined as fasting blood sugar (FBS) > 110 mg/dl, or having a history of oral hypoglycemic agents; and elevated SGOT and SGPT were defined as SGOT > 40 U/L and SGPT > 40 U/L, respectively. Results: The BMI mean±SD values of Iranian seafarers were 24.81±3.07 kg/m2, 25.51±2.96 kg/m2, and 25.96 ± 3.02 kg/m2 in 2010, 2012, and 2014, respectively. A significant difference was observed in BMI over the study period. The mean of systolic and diastolic blood pressure did not significantly increase over time. The SGOT and SGPT means were not significantly different from 2010 to 2014. The prevalence of overweight increased significantly from 46.7% to 60.9% over the study period; however, the prevalence of obesity, hypertension, elevated SGOT, and elevated SGPT did not change significantly. Conclusion: The current survey showed that the obesity problem has increased among Iranian seafarers working on tankers, which is a concerning problem because obesity has negative effects on seafarers' health.
Background: Little information is available on the trend in cardiovascular risk factors and hepatic enzymes in Iranian seafarers. The present study aimed at assessing the pattern of obesity, hypertension, diabetes, elevated serum glutamic oxaloacetate transaminase (SGOT), and serum glutamate pyruvate transaminase (SGPT) in Iranian seafarers during 2010 to 2014. Methods: Data on cardiovascular risk factors and hepatic enzymes were extracted from seafarers' annual health examination of National Iranian Tanker Company (NITC) of 2010, 2012, and 2014. The repeated measure ANOVA was used to compare continuous variables across 3 years. Categorical data were analyzed using Chi-square test. Over weight was defined as BMI (Body Mass Index) >25 kg/m2; obesity was defined as BMI>=30 kg/m2; hypertension was defined as systolic blood pressure (SBP)> 140 mmHg, and diastolic blood pressure (DBP)> 90 mmHg, or a history of antihypertensive drug use. Diabetes (DM) was defined as fasting blood sugar (FBS) > 110 mg/dl, or having a history of oral hypoglycemic agents; and elevated SGOT and SGPT were defined as SGOT > 40 U/L and SGPT > 40 U/L, respectively. Results: The BMI mean±SD values of Iranian seafarers were 24.81±3.07 kg/m2, 25.51±2.96 kg/m2, and 25.96 ± 3.02 kg/m2 in 2010, 2012, and 2014, respectively. A significant difference was observed in BMI over the study period. The mean of systolic and diastolic blood pressure did not significantly increase over time. The SGOT and SGPT means were not significantly different from 2010 to 2014. The prevalence of overweight increased significantly from 46.7% to 60.9% over the study period; however, the prevalence of obesity, hypertension, elevated SGOT, and elevated SGPT did not change significantly. Conclusion: The current survey showed that the obesity problem has increased among Iranian seafarers working on tankers, which is a concerning problem because obesity has negative effects on seafarers' health.
The rate of diabetes and obesity is increasing exponentially.The prevalence of cardiovascular risk factors have increased during the recent years among the seafarers in various countries.
→ What this article adds:
The obesity has an increasing among Iranian seafarers working
on tankers during 2010-2014.This is a main concern because
obesity has negative effects on the health condition of the seafarers.
Introduction
Cardiovascular disease (CVD) is the main cause of death in the world (1), and its prevalence has increased in developing countries (2). Overweight, obesity, arterial hypertension, and hypercholesterolemia are some of the main risk factors causing the highest share of cardiovascular disease (3). Statistics show that death due to CVD is 33.7% in low-and middle-income countries (4). The increase in CVD morbidity and mortality in developing countries is associated with increased prevalence of cardiovascular risk factors (5). Several research have studied the prevalence of cardiovascular risk factors and their trends over time in normal population. Data show that about 180 million people have diabetes which will be doubled by the year 2030 in the developing world (6). The prevalence of obesity among adult population was 396 million in 2005, and it is estimated to reach 573 million by 2030 (7).In 2008, a national study in Iran indicated that 7.7% of Iranian adults had diabetes, and 16.8% had impaired fasting glucose (8). Also, the estimated total number of Iranian obese males and females in 2005 was 42.8% and 57%, respectively (9). Based on the current studies on Iranian seafarers, the prevalence of MetS (Metabolic Syndrome) was 15%, and a large proportion of them had abdominal obesity (10). By 2015, these numbers are projected to be 54% and 74%, respectively (11). Previous studies revealed that the prevalence of hypertension among Iranian adults was 25.2% in 2005 (12); this figure reached to 26.6% in 2007 (13). Moreover, the majority of the patients with nonalcoholic fatty liver disease (NAFLD), who are obese, suffer abdominal obesity, Type 2 diabetes, and other cardiovascular risk factors (14). Results of the National Health and Nutrition Examination Survey (NHANES) revealed that about 70% of the elevated aminotransferase activity was significantly associated with higher body mass index, waist circumference, triglycerides, fasting insulin, and lower high density lipoprotein (HDL) cholesterol (15).Seafaring is a crucial job in Iran, and the literature review shows that the prevalence of cardiovascular risk factors have increased during the recent years among the seafarers (16). Moreover, the prevalence of overweight, hypertension, and hypercholesterolemia increased during 1990s and 2000s among seafarers form various countries (16). Data revealed that the prevalence of obesity among Turkish seafarers has increased, and the highest level of BMI was observed among seafarers aged 50 to 60 years (17). Little is known about the trend in cardiovascular risk factors and hepatic enzymes in Iranian seafarers. Accordingly, the present study aimed at assessing the pattern of obesity, hypertension, diabetes, elevated SGOT, and SGPT in Iranian seafarers during 2010 to 2014.
Methods
Data
A retrospective cohort study was conducted, examining 500 Iranian male seafarers of NITC, who referred to health units for annual health examination to assess some patterns of risk factors of cardiovascular disease and liver enzymes. From 500 participants, 169 (33%) seafarers had at least 6 months of sea services and complete medical-demographic data in 2010, 2012, and 2014.Data on cardiovascular risk factors and hepatic enzymes were derived from seafarers’ annual health examination of NITC of 2010, 2012, and 2014. The health examination data included age, height, weight, FBS, SGOT and SGPT, systolic, and diastolic blood pressure.
Measurement
Anthropometric parameters including height, weight, and blood pressure were measured according to standardized protocols. Weight was measured in light clothing without shoes using an electronic scale (Seca, 707; range 0.1-150 kg); height was measured without shoes using a tape meter, stadiometer. Body mass index (BMI) was calculated as weight (kg)/height2 (m2). Systolic and diastolic blood pressure were measured twice after 15 minutes rest and averaged in seated position, applying a standard mercury sphygmomanometer.FBS (after 12-14 hours fasting), SGOT, and SGPT were tested using the relevant kits obtained from the Pars Azmoon Company, Iran, by an automatic analytical machine (BT3000, Italy).Overweight was defined as BMI>25 kg/m2; obesity was defined as BMI>=30 kg/m2. High systole and high diastole were defined as systolic blood pressure (SBP)>140 mmHg and diastolic blood pressure (DBP)> 90 mmHg, respectively. Hypertension was defined as systolic blood pressure (SBP)> 140 mmHg and diastolic blood pressure (DBP)> 90 mmHg or a history of antihypertensive drug use (18). Diabetes was defined as fasting blood glucose > 110 mg/dL, or having a history of oral hypoglycemic agents (18). Elevated SGOT and SGPT were defined as SGOT > 40 U/L and SGPT > 40 U/L, respectively (19).
Ethical Considerations
This study was proposed and approved by the Ethics-in-Research Commission of Iran University of Medical Sciences. Also, permission was achieved from NITC to use Iranian seafarer information.
Statistical Analysis
The data were analyzed using SPSS16. Continuous variables were reported in mean and standard deviation (SD). The repeated measure ANOVA was used to compare continuous variables across 3 years. Categorical data were analyzed using Chi-square test. The significant level was set at p <0.05.
Results
The mean (SD) age of Iranian seafarers was 42.8 (10.4) years, and the mean (SD) job history was 16.7 (10.60) years. A total of 89 (52.7%) and 80 (47.3%) of the participants had diploma and academic degree, respectively; 77 (45.6%) did shift work.Table 1 demonstrates the mean of BMI, FBS, SBP, DBP, and hepatic enzymes among participants in 3 intervals. The BMI mean of the participants significantly increased from 2010 to 2014 (p<0.001). In 2010, the mean (SD) values of SBP and DBP were 119.46 (13.22) mmHg and 75.94 (8.74) mmHg, respectively. In 2014, these mean values were 122.38 (14.41) mmHg and 78.89 (9.49) mmHg, respectively; however, this increase was not statistically significant (p= 0.062). Although the FBS mean decreased over the study period, it was not statistically significant (p= 0.22). The mean values of SGOT and SGPT did not change significantly among participants from 2010 to 2014.
Table 1
Mean±SD of the cardiovascular risk factors and hepatic enzymes on the participants from 2010 to 2014
Year, Mean ±SD
Risk Factors
2010
2012
2014
P-Trend
BMI
24.81±3.07
25.51±2.96
25.96±3.02
<0.001
Systolic blood pressure
119.46±13.22
119.14±15.10
122.38±14.41
NS
Diastolic blood pressure
75.94±8.74
74.95±9.99
78.89±9.49
NS
Fasting blood glucose
96.24±13.82
95.68±13.40
95.53±18.13
NS
SGOT
23.76±9.27
21.52±7.93
25.57±9.21
NS
SGPT
32.29±18.55
28.47±13.92
32.20±16.02
NS
The prevalence of cardiovascular risk factors and hepatic enzyme among Iranian seafarers are presented in Table 2. The prevalence of overweight increased significantly from 46.7% to 60.9% over the study period. Although the prevalence of obesity enhanced from 4.1% to 8.9%, it was not statistically significant. The rate of high SBP, high DBP, HTN, and diabetes increased from 2010 to 2014; however, the changes were not significant. The prevalence of elevated SGOT and SGPT were 6.5% and 25.4% in 2010, respectively; this prevalence was 5.9% and 21.3% in 2014, respectively, indicating no significant change between 2010 and 2014 prevalence values.
Table 2
Prevalence of cardiovascular risk factors and hepatic enzymes on the participants from 2010 to 2014
Year, Prevalence, %
Risk factors
2010
2012
2014
Relative Change From 2010 to 2014, %
P value
Obesity
7 (4.1)
10 (5.9)
15 (8.9)
114
NS
Overweight
79 (46.7)
99 (58.6)
103 (60.9)
30.37
<0.01
High systole
16 (9.5)
20 (11.8)
25 (14.8)
56.25
NS
High diastole
20 (11.8)
35 (20.7)
24 (14.2)
20
NS
Hypertension
26 (15.4)
41 (24.3)
40 (23.7)
53.84
NS
Diabetes
37 (21.9)
33 (19.5)
49 (29.0)
32.43
NS
Elevated SGOT
11 (6.5)
4 (2.4)
10 (5.9)
-9.09
NS
Elevated SGPT
43 (25.4)
25 (14.8)
36 (21.3)
-16.27
NS
Overweight& Hypertension
21 (12.4)
26 (15.4)
30 (17.8)
42.85
NS
Overweight& Diabetes
23 (13.6)
16 (9.5)
28 (16.6)
21.73
NS
Hypertension& Diabetes
10 (5.9)
8 (4.7)
10 (5.9)
0
NS
Hypertension& Diabetes& Overweight
27 (16.9)
35 (21.3)
38 (23.9)
40.74
NS
Elevated SGOT& Elevated SGPT
10 (5.9)
4 (2.4)
7 (4.1)
-30.0
NS
Figures 1-3 demonstrates the frequency of different combinations of cardiovascular risk factors from 2010 to 2014. The prevalence of having “HTN and obesity” did not change significantly over time, but the frequency of having “HTN and overweight” significantly increased from 12.4% to 17.8%. The frequency of combination of DM-overweight significantly increased from 2010 to 2014. Also, the prevalence of having diabetes-overweight-HTN among Iranian seafarers increased significantly from 5.3% to 5.9% between 2010 until 2014 (p<0.05).
Fig. 1
Fig. 3
Frequency of Combination of HTN; a: Obesity, b: OverweightFrequency of combination of diabetes. a: Overweight, b: HTNFrequency of combination of diabetes and HTN and overweight
Discussion
The current study provides primary data on the increasing trend of overweight in Iranian seafarers’ population over the study period. The prevalence of hypertension, diabetes, elevated SGOT, and SGPT increased non-significantly from 2010 to 2014. Studies have found that the risk factors of non-communicable diseases’ trend have been increasing in both developing and developed countries (20-22). The prevalence of obesity among American adults increased from 13% to 32% between 1960s and 2004 (23,24). Similar increasing trend of diabetes is reported in adults’ population in the USA (25). The prevalence of obesity in Europe has doubled over the past 10 to 15 years (26). In developing countries, the increasing prevalence of diabetes is estimated to increase from 3.3% to 4.9% from 1995 to 2025 (27). A similar increase in obesity prevalence has been observed in developing countries (20); in Kuwait and Oman, the obesity prevalence rate has risen in recent years. The national prevalence of obesity in Kuwait increased from 15% to 28% from 1980 to 1994 (28), and in Oman, it increased from 10.5% to 16.7% from 1991 to 2000 (29). Recent studies have revealed that cardiovascular diseases risk factors have also increased in Iranian adults’ population (3,13,30,31). Data from the National Survey of Risk Factors of Non-Communicable Diseases (SuRFNCD) showed that the prevalence of obesity increased from 13.6% in 1999 to 19.6% in 2005 and to 22.3% in 2007 among Iranian adults. During these years, the national prevalence of overweight was 32.2%, 35.8%, and 36.3%, respectively; ie, 4.1% increase in 8 years (3). According to SuRFNCD, the rate of diagnosed diabetes was 2.5%, 4.0%, and 4.6% in 1999, 2005, and 2007, respectively; ie, during 8 years, the prevalence of diabetes rose more than 1.8 fold among Iranian adults (31). In 2005, the national prevalence of hypertension was 25.2%; this number was 26.6% (1.4% increase in 2 years) in 2007 (13). Other studies presented alarming increases in the prevalence of overweight, obesity, and abdominal obesity in different regions of Iran (30,32,33). Possible reasons which can be accounted for increase in the prevalence of non-communicable diseases are improper dietary habits, inactivity, speedy urbanization, and imparity in health care (34).The prevalence of cardiovascular risk factors are high among seafarers, which might be due to their different lifestyle (16). In the current study, the overweight trend increased significantly among seafarers by 14.2% from 2010 to 2014. The mean of BMI significantly increased among Iranian seafarers over time. The present findings are consistent with other studies (16,17,35). A review on the prevalence of cardiovascular risk factors among seafarers during 1990s and 2000s showed that the prevalence of overweight was 47.1% in 1990s and 64.1% in 2000s; and the prevalence of overweight increased significantly over time (16). Findings of Nas revealed that the mean of BMI among Turkish seafarers significantly raised from 2009 to 2012, and when the Turkish seafarers got older, their BMI values increased gradually (17). A survey was performed among Danish seafarers to find the trend of BMI from 2001/2002 to 2010, showing that the overweight prevalence was 64% in 2001/2002 and increased to 70.5% in 2010; and the relative risk of being overweight in 2010 was 1.08 compared to 2001/2002 (35). Published data show that the prevalence of high blood pressure significantly increased from 14.8% in 1990s to 42.1% in 2000s among seafarers (16), which is inconsistent with the present study. In our study, the mean of SBP and DBP did not increase significantly, and the trend of high systole, high diastole, and hypertension rose nonsignificantly among Iranian seafarers from 2010 to 2014. The findings revealed that the mean of fasting blood glucose did not change significantly over time, and the trend of diabetes did not increase significantly. The results are consistent with Pougnet et al.’s study (16), in which the prevalence of glycemic abnormalities or diabetes increased nonsignificantly from 3.9% to 4.0% during 1990s and 2000s. Documentaries show that factors such as inactivity, lack of sleeping, stress of work, unhealthy diet, and long job duration contribute to increase in cardiovascular risk factors among seafarers (36).In our study, the mean of hepatic enzymes increased non-significantly from 2010 to 2014 among Iranian seafarers, hich might have been due to the short duration of the study or small sample size. Elevated level of SGPT is the main liver abnormality in NAFLD and nonalcoholic steatohepatitis (NASH). Statistics showed that the NAFLD prevalence was 25% among American adults (37). Previous studies have revealed significant associations between components of metabolic syndrome and NAFLD and NASH (38). The prevalence of elevated SGPT among Iranian population is 4.3%, suggesting that the rate of NAFLD/NASH and related complications are expected to rise among Iranian population in the future (39). Recent evidences indicate that NAFLD is the main common reason of liver disease in Iran (40).The main strength of the study was that it was the first study to report the pattern of cardiovascular risk factors and liver enzymes among Iranian seafarers working on tankers. The study had a number of limitations: Nutritional habits and physical activity were not considered simultaneously in the study, moreover, the study was conducted in a short-term; and in this regard small sample size might have been the main reason for non-significant results of the current survey. Thus, the results may not be appropriately generalized.
Conclusions
The current survey showed that the obesity problem has increased among Iranian seafarers working on tankers in the recent years, which is a main concern because obesity has negative effects on the health condition of the seafarers. Longitudinal studies on seafarers are needed to investigate the trend of cardiovascular risk factors and other risk factors of this occupation.
Acknowledgments
The study data were derived from the PhD thesis of Ms. Fereshteh Baygi, a student of the Occupational Health Research Center of Iran University of Medical Sciences. The authors gratefully acknowledge the financial support of Iran University of Medical Sciences (Grant No. 25800). The authors would like to thank the manager and participants of National Iranian Tanker Company for their contribution.
Authors: Richard Pougnet; Laurence Pougnet; Brice Loddé Loddé; Maria Luisa Canals-Pol; Dominique Jegaden; David Lucas; Jean-Dominique Dewitte Journal: Int Marit Health Date: 2013
Authors: Fereshteh Baygi; Olaf C Jensen; Mostafa Qorbani; Aliasghar Farshad; Seyed Ali Salehi; Fatemeh Mohammadi-Nasrabadi; Hamid Asayesh; Farzad Shidfar Journal: Int Marit Health Date: 2016
Authors: Patricia M Kearney; Megan Whelton; Kristi Reynolds; Paul Muntner; Paul K Whelton; Jiang He Journal: Lancet Date: 2005 Jan 15-21 Impact factor: 79.321
Authors: Catherine C Cowie; Keith F Rust; Earl S Ford; Mark S Eberhardt; Danita D Byrd-Holt; Chaoyang Li; Desmond E Williams; Edward W Gregg; Kathleen E Bainbridge; Sharon H Saydah; Linda S Geiss Journal: Diabetes Care Date: 2008-11-18 Impact factor: 17.152